107 related articles for article (PubMed ID: 22283657)
1. The use of specific monoclonal antibodies to target immunogenic tumor membrane proteins in patients with recurrent pancreatic and colon cancer.
Arlen M; Wang X; Luka J; Gupta R; Saric O; Arlen PM
Curr Drug Deliv; 2012 Jan; 9(1):52-6. PubMed ID: 22283657
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor activity of a novel monoclonal antibody, NPC-1C, optimized for recognition of tumor antigen MUC5AC variant in preclinical models.
Patel SP; Bristol A; Saric O; Wang XP; Dubeykovskiy A; Arlen PM; Morse MA
Cancer Immunol Immunother; 2013 Jun; 62(6):1011-9. PubMed ID: 23591984
[TBL] [Abstract][Full Text] [Related]
3. The therapeutic value of monoclonal antibodies directed against immunogenic tumor glycoproteins.
Arlen M; Arlen P; Tsang A; Wang X; Gupta R
J Cancer; 2010 Nov; 1():209-22. PubMed ID: 21060731
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy of colon cancer using chimeric mAb 31.1.
Arlen M; Tsang A; Wang T
Crit Rev Immunol; 1998; 18(1-2):133-8. PubMed ID: 9419455
[TBL] [Abstract][Full Text] [Related]
5. Rapid and specific targeting of monoclonal antibody A33 to a colon cancer xenograft in nude mice.
Barendswaard EC; Scott AM; Divgi CR; Williams C; Coplan K; Riedel E; Yao TJ; Gansow OA; Finn RD; Larson SM; Old LJ; Welt S
Int J Oncol; 1998 Jan; 12(1):45-53. PubMed ID: 9454885
[TBL] [Abstract][Full Text] [Related]
6. A rapid and efficient in vivo method for determining the biologic efficacy of monoclonal antibodies in animal models of cancer.
Staquet K; Giles-Komar J
Hybridoma (Larchmt); 2006 Apr; 25(2):68-74. PubMed ID: 16704306
[TBL] [Abstract][Full Text] [Related]
7. Cellular and humoral immune responses to a human pancreatic cancer antigen, coactosin-like protein, originally defined by the SEREX method.
Nakatsura T; Senju S; Ito M; Nishimura Y; Itoh K
Eur J Immunol; 2002 Mar; 32(3):826-36. PubMed ID: 11870627
[TBL] [Abstract][Full Text] [Related]
8. A novel human monoclonal antibody derived from tumor-infiltrating lymphocytes in lung cancer inhibits cancer cell growth with morphological changes.
Aoki M; Saikawa Y; Hosokawa S; Fukuda K; Kumai K; Kubota T; Yoshida M; Otani Y; Kitajima M
Anticancer Res; 2005; 25(6B):3791-8. PubMed ID: 16309165
[TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of monoclonal antibody 14C5 for targeting pancreatic cancer.
Vervoort L; Burvenich I; Staelens S; Dumolyn C; Waegemans E; Van Steenkiste M; Baird SK; Scott AM; De Vos F
Cancer Biother Radiopharm; 2010 Apr; 25(2):193-205. PubMed ID: 20423233
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo activity of MT201, a fully human monoclonal antibody for pancarcinoma treatment.
Naundorf S; Preithner S; Mayer P; Lippold S; Wolf A; Hanakam F; Fichtner I; Kufer P; Raum T; Riethmüller G; Baeuerle PA; Dreier T
Int J Cancer; 2002 Jul; 100(1):101-10. PubMed ID: 12115595
[TBL] [Abstract][Full Text] [Related]
11. Cancer vaccines: an update with special focus on ganglioside antigens.
Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
[TBL] [Abstract][Full Text] [Related]
12. Human monoclonal antibody prepared from lymphocytes of pancreatic cancer patients.
Tanaka H; Chung YS; Nakata B; Satake K; Umeyama K; Murakami H
Pancreas; 1989; 4(5):572-80. PubMed ID: 2813327
[TBL] [Abstract][Full Text] [Related]
13. A novel tumor-specific human single-chain Fv selected from an active specific immunotherapy phage display library.
Hall BL; Boroughs J; Kobrin BJ
Immunotechnology; 1998 Oct; 4(2):127-40. PubMed ID: 9853954
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic cancer immunotherapy using a tumor lysate vaccine, engineered to express α-gal epitopes, targets pancreatic cancer stem cells.
Tanida T; Tanemura M; Miyoshi E; Nagano H; Furukawa K; Nonaka Y; Akita H; Hama N; Wada H; Kawamoto K; Kobayashi S; Eguchi H; Mori M; Doki Y
Int J Oncol; 2015 Jan; 46(1):78-90. PubMed ID: 25354268
[TBL] [Abstract][Full Text] [Related]
15. Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigens.
Sharkey RM; Gold DV; Aninipot R; Vagg R; Ballance C; Newman ES; Ostella F; Hansen HJ; Goldenberg DM
Cancer Res; 1990 Feb; 50(3 Suppl):828s-834s. PubMed ID: 2297729
[TBL] [Abstract][Full Text] [Related]
16. The generation of monoclonal antibodies against human pancreatic exocrine cancer: a study of six different immunisation regimes.
Grant AG; Harris PM; Heyderman E; Larkin SE; Pym B; Hermon-Taylor J
Br J Cancer; 1985 Oct; 52(4):543-50. PubMed ID: 4063133
[TBL] [Abstract][Full Text] [Related]
17. Alteration of the Tumor Stroma Using a Consensus DNA Vaccine Targeting Fibroblast Activation Protein (FAP) Synergizes with Antitumor Vaccine Therapy in Mice.
Duperret EK; Trautz A; Ammons D; Perales-Puchalt A; Wise MC; Yan J; Reed C; Weiner DB
Clin Cancer Res; 2018 Mar; 24(5):1190-1201. PubMed ID: 29269377
[No Abstract] [Full Text] [Related]
18. Tumor localization and biodistribution with radiolabeled monoclonal antibody against pancreatic cancer in tumor-bearing nude mice.
Chung YS; Sawada T; Kondo Y; Ho JJ; Kim YS; Sowa M
Tohoku J Exp Med; 1992 Oct; 168(2):397-401. PubMed ID: 1306326
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy.
Amedei A; Niccolai E; Prisco D
Hum Vaccin Immunother; 2014; 10(11):3354-68. PubMed ID: 25483688
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of recombinant GA733-2E antigen (CO17-1A, EGP, KS1-4, KSA, Ep-CAM) in gastro-intestinal carcinoma patients.
Staib L; Birebent B; Somasundaram R; Purev E; Braumüller H; Leeser C; Küttner N; Li W; Zhu D; Diao J; Wunner W; Speicher D; Beger HG; Song H; Herlyn D
Int J Cancer; 2001 Apr; 92(1):79-87. PubMed ID: 11279610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
